CS logo
small CS logo
Inland Rheumatology; Clinical Trials, Inc.

Upland, California, United States
Research institute in Upland, California
1238 E Arrow Hwy, Upland, CA 91786

About Inland Rheumatology; Clinical Trials, Inc.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
12
Eli Lilly and Company
11
Bristol-Myers Squibb
5
Amgen
4
Boehringer Ingelheim
4
Hoffmann-La Roche
3
Janssen Research & Development, LLC
3
R-Pharm International, LLC
3
Biogen
2
Celgene
2
Gilead Sciences
2
Total Rows: 28

Clinical Trials at Inland Rheumatology; Clinical Trials, Inc.


During the past decade, Inland Rheumatology; Clinical Trials, Inc. conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 43 clinical trials were completed, i.e. on average, 97.7% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 20 clinical trials were completed. i.e. 153.8% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years441010994444665522111110107744776666Started TrialsCompleted Trails20152016201720182019202020212022051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate
2006-01-23
2012-05-28
Completed
103
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081

Rows per page:

1–69 of 69

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Inland Rheumatology; Clinical Trials, Inc." #1 sponsor was "Pfizer" with 12 trials, followed by "Eli Lilly and Company" with 11 trials sponsored, "Bristol-Myers Squibb" with 5 trials sponsored, "Amgen" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 28 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Inland Rheumatology; Clinical Trials, Inc." #1 collaborator was "Incyte Corporation" with 4 trials as a collaborator, "OCT Clinical Trials" with 3 trials as a collaborator, "Galapagos NV" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "PPD" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 15 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 12Pfizer: 12Eli Lilly and Company: 11Eli Lilly and Company: 11Bristol-Myers Squibb: 5Bristol-Myers Squibb: 5Amgen: 4Amgen: 4Boehringer Ingelheim: 4Boehringer Ingelheim: 4Hoffmann-La Roche: 3Hoffmann-La Roche: 3Janssen Research &Development, LLC: 3Janssen Research &Development, LLC: 3R-Pharm International, LLC: 3R-Pharm International, LLC: 3Biogen: 2Biogen: 2Celgene: 2Celgene: 2

Created with Highcharts 11.1.0Top CollaboratorsIncyte Corporation: 4Incyte Corporation: 4OCT Clinical Trials: 3OCT Clinical Trials: 3Galapagos NV: 2Galapagos NV: 2Merck KGaA,Darmstadt, Germany: 2Merck KGaA,Darmstadt, Germany: 2PPD: 2PPD: 2Quintiles, Inc.: 2Quintiles, Inc.: 2Daiichi Sankyo Co., Ltd.: 1Daiichi Sankyo Co., Ltd.: 1Gilead Sciences: 1Gilead Sciences: 1Hexal AG: 1Hexal AG: 1IQVIA Pvt. Ltd: 1IQVIA Pvt. Ltd: 1

Clinical Trials Conditions at Inland Rheumatology; Clinical Trials, Inc.


According to Clinical.Site data, the most researched conditions in "Inland Rheumatology; Clinical Trials, Inc." are "Rheumatoid Arthritis" (27 trials), "Systemic Lupus Erythematosus" (12 trials), "Arthritis, Rheumatoid" (9 trials), "Lupus Erythematosus, Systemic" (7 trials) and "Low Back Pain" (2 trials). Many other conditions were trialed in "Inland Rheumatology; Clinical Trials, Inc." in a lesser frequency.

Clinical Trials Intervention Types at Inland Rheumatology; Clinical Trials, Inc.


Most popular intervention types in "Inland Rheumatology; Clinical Trials, Inc." are "Drug" (61 trials), "Biological" (11 trials), "Other" (9 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (24 trials), "Baricitinib" (7 trials), "Methotrexate" (4 trials), "Abatacept" (3 trials) and "Adalimumab" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Inland Rheumatology; Clinical Trials, Inc.


The vast majority of trials in "Inland Rheumatology; Clinical Trials, Inc." are 68 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Inland Rheumatology; Clinical Trials, Inc.


Currently, there are NaN active trials in "Inland Rheumatology; Clinical Trials, Inc.". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 48 completed trials in Inland Rheumatology; Clinical Trials, Inc., undefined suspended trials, and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Inland Rheumatology; Clinical Trials, Inc., 1 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 30Phase 3: 30Phase 2: 29Phase 2: 29Phase 4: 12Phase 4: 12Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 48Completed: 48Terminated: 8Terminated: 8Active, not recruiting: 6Active, not recruiting: 6Recruiting: 6Recruiting: 6Enrolling by invitation: 1Enrolling by invitation: 1